JPS6160802B2 - - Google Patents
Info
- Publication number
- JPS6160802B2 JPS6160802B2 JP2033081A JP2033081A JPS6160802B2 JP S6160802 B2 JPS6160802 B2 JP S6160802B2 JP 2033081 A JP2033081 A JP 2033081A JP 2033081 A JP2033081 A JP 2033081A JP S6160802 B2 JPS6160802 B2 JP S6160802B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- oxy
- effect
- cosmetic
- fair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002537 cosmetic Substances 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- VEYIMQVTPXPUHA-UHFFFAOYSA-N 3-hydroxypyran-4-one Chemical compound OC1=COC=CC1=O VEYIMQVTPXPUHA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 5
- IQXWFHDFTAZGNB-UHFFFAOYSA-N 5-hydroxy-2-methylpyran-4-one Chemical compound CC1=CC(=O)C(O)=CO1 IQXWFHDFTAZGNB-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- XPCTZQVDEJYUGT-UHFFFAOYSA-N allomaltol Natural products CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 4
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008294 cold cream Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 2
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 2
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical class O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- DSJNICGAALCLRF-UHFFFAOYSA-L magnesium;oxidooxy(oxo)borane Chemical compound [Mg+2].[O-]OB=O.[O-]OB=O DSJNICGAALCLRF-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940105296 zinc peroxide Drugs 0.000 description 1
- PLVWNARVBMHCST-UHFFFAOYSA-L zinc;oxidooxy(oxo)borane Chemical compound [Zn+2].[O-]OB=O.[O-]OB=O PLVWNARVBMHCST-UHFFFAOYSA-L 0.000 description 1
- -1 γ-pyrone compound Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】
本発明は2−アルキル−5−オキシ−γ−ピロ
ン化合物を含有せしめた美白効果および日焼防止
効果の大なる色白化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a skin-whitening cosmetic containing a 2-alkyl-5-oxy-γ-pyrone compound, which has great whitening and sun protection effects.
色白の美しい肌にしたいと願うのは女性の常で
あり、従来より過酸化水素、過酸化亜鉛、過酸化
マグネシウム、過酸化ナトリウム、過ホウ酸亜
鉛、過ホウ酸マグネシウムまたは過ホウ酸ナトリ
ウムなどの過酸化物を配合した化粧料が使用され
ていた。しかしながら前記のごとき過酸化物はき
わめて不安定な物質であるため、保存性あるいは
化粧料への配合性などの点に問題があり、かつそ
の美白効果も充分ではなかつた。近年になつて、
ビタミンC、システイン、コロイド硫黄などを配
合した化粧料が開発され賞用されているが、これ
らとてもなお充分に満足しうるものとはいいがた
い。 It is common for women to want to have fair and beautiful skin, and traditionally, treatments such as hydrogen peroxide, zinc peroxide, magnesium peroxide, sodium peroxide, zinc perborate, magnesium perborate, or sodium perborate have been used. Cosmetics containing peroxide were used. However, since the above-mentioned peroxides are extremely unstable substances, there are problems in terms of storage stability and incorporation into cosmetics, and their whitening effect is not sufficient. In recent years,
Cosmetics containing vitamin C, cysteine, colloidal sulfur, etc. have been developed and are now in use, but they are still far from being fully satisfactory.
しかるに、本発明者は人体に好ましくない副作
用を有せず、かつすぐれた美白効果を奏する配合
剤を見出すべく永年にわたつて研究を重ねてきた
ところ、一般式:
(式中、Rは低級アルキル基である)で示され
る2−アルキル−5−オキシ−γ−ピロン化合物
がとりわけすぐれたメラニン生成抑制作用を有
し、絶大なる美白効果および日焼防止効果を奏す
るというまつたく新たな事実を見出し、本発明を
完成するにいたつた。 However, the inventors of the present invention have conducted extensive research over many years in order to find a compound that does not have any undesirable side effects on the human body and has an excellent whitening effect, and has found the general formula: The 2-alkyl-5-oxy-γ-pyrone compound represented by the formula (wherein R is a lower alkyl group) has a particularly excellent melanin production inhibiting effect, and has an outstanding whitening effect and sun protection effect. Having discovered this new fact, we have now completed the present invention.
すなわち本発明は適宜の化粧料基材に2−アル
キル−5−オキシ−γ−ピロン化合物を含有せし
めることを要旨とする色白化粧料であつて、ここ
に化粧料基材としては従来より多用されている
種々の基礎化粧料基材、たとえば各種アルコール
類、動植物脂肪、界面活性剤、ペクチン、カルボ
キシメチルセルロース、アルギン酸塩、さらには
安定剤、色素、香料およびその他の成分を適宜配
合し、要すれば加熱溶融または溶融撹拌したもの
などがすべてそのまま採用可能である。 That is, the present invention is a fair-skinned cosmetic comprising a 2-alkyl-5-oxy-γ-pyrone compound contained in a suitable cosmetic base, and wherein a 2-alkyl-5-oxy-γ-pyrone compound is contained in a suitable cosmetic base. Various basic cosmetic base materials, such as various alcohols, animal and vegetable fats, surfactants, pectin, carboxymethyl cellulose, alginates, as well as stabilizers, pigments, fragrances and other ingredients, are blended as appropriate, and if necessary. Anything that has been heated and melted or melted and stirred can be used as is.
本発明に美白剤として用いられる2−アルキル
−5−オキシ−γ−ピロン化合物は、従来のその
作用効果についてほとんど未知の物質であり、か
かる2−アルキル−5−オキシ−γ−ピロン化合
物が人体皮膚のチロジナーゼの作用を阻害し、メ
ラニン生成を抑制して顕著な美白効果を奏するこ
とは従来何人も予期しえなかつたことであり、本
発明者によとつて初めて明らかにされたものであ
る。 The 2-alkyl-5-oxy-γ-pyrone compound used as a skin whitening agent in the present invention is a substance whose action and effect are almost unknown. The fact that it inhibits the action of tyrosinase in the skin and inhibits melanin production, resulting in a remarkable whitening effect, was something that no one could have predicted before, and was revealed for the first time by the present inventor. .
好適に採用される2−アルキル−5−オキシ−
γ−ピロン化合物としては、たとえばアロマルト
ールなどが代表例としてあげられる。これらのγ
−ピロン化合物のメラニン生成抑制作用につい
て、つぎに実験例をあげて説明する。 2-alkyl-5-oxy- preferably employed
A representative example of the γ-pyrone compound is allomaltol. These γ
- The melanin production inhibiting effect of pyrone compounds will be explained below with reference to experimental examples.
実験例
0.01%(重量%、以下同様)マロマルトール水
溶液を調製した。Experimental Example A 0.01% (wt%) malomaltol aqueous solution was prepared.
ついで、試験管にL−チロジン溶液(0.3mg/
ml)を1ml、マツクルベイン氏の緩衝液(PH
6.8)を1mlおよび前記アロマトール水溶液を0.9
ml入れて37℃の恒温水槽中で10分間インキユベー
トしたのち、これにチロジナーゼ溶液(1mg/
ml)を0.1ml加えてよく撹拌し、ただちに分光光
度計にセツトして475mμにおける吸光度を経時
的(分単位)に測定し、生成してくる赤色のドー
パクローム(メラニン色素の前駆物質)の生成量
と時間との関係を求めた。 Next, add L-tyrosine solution (0.3 mg/
ml) and 1 ml of Matsukulbane's buffer solution (PH
6.8) and 0.9 mL of the above aromatol aqueous solution.
After incubating for 10 minutes in a thermostatic water bath at 37°C, add tyrosinase solution (1 mg/ml) to this.
ml), stir well, and immediately set it in a spectrophotometer to measure the absorbance at 475 mμ over time (in minutes) to determine the formation of red dopachrome (precursor of melanin pigment). We sought the relationship between quantity and time.
添付図面は以上の実験結果を示すグラフである
が、このグラフからアロマルトールがメラニン色
素の前駆物質であるドーパクロームの生成を強力
に抑制する作用を有しており、したがつてすぐれ
た美白効果、日焼防止効果を奏するものであるこ
とがわかる。 The attached drawing is a graph showing the above experimental results, and this graph shows that allomaltol has the effect of strongly suppressing the production of dopachrome, which is a precursor of melanin pigment, and is therefore an excellent whitening agent. It can be seen that it has a sunburn prevention effect.
かかる3(または5)−オキシ−γ−ピロン化
合物は、前記実験結果からわかるように通常0.01
%水溶液ですぐれたドーパクローム生成抑制効果
を発揮するものであり、化粧料基材に2−アルキ
ル−5−オキシ−γ−ピロン化合物を含有せしめ
て本発明の色白化粧料をうるばあい、その含有量
は5%以下、なかんずく0.01〜2.0%程度で充分
であり、このように微量であつても本発明の目的
を完全に達成することができる。 As can be seen from the above experimental results, such 3 (or 5)-oxy-γ-pyrone compounds usually have a concentration of 0.01
% aqueous solution exhibits an excellent effect of inhibiting dopachrome formation, and when the fairing cosmetic of the present invention is prepared by incorporating a 2-alkyl-5-oxy-γ-pyrone compound into a cosmetic base material, A content of 5% or less, especially about 0.01 to 2.0%, is sufficient, and even with such a small amount, the purpose of the present invention can be completely achieved.
またかかる2−アルキル−5−γ−ピロン化合
物は一般に化粧料基材に対する配合性が良好であ
り、かつPH、熱、脱色などに対する経時変化が小
さく安定性が良好であるから、これを含有せしめ
た本発明の色白化粧料は保管中に効能が低下した
り、変質したりすることのない優秀な製品であ
る。 In addition, such 2-alkyl-5-γ-pyrone compounds generally have good blendability in cosmetic base materials, and have good stability with little change over time against pH, heat, decolorization, etc., so they may be included. The fair skin cosmetic of the present invention is an excellent product that does not deteriorate in efficacy or change in quality during storage.
つぎに本発明の色白化粧料の処方例を列挙する
が、本発明はもとよりこれらの処方例のみに限定
されるものではない。 Next, formulation examples of the fair skin cosmetic of the present invention will be listed, but the present invention is not limited to these formulation examples.
処方例 1〔ローシヨン〕
(成 分) (重量部)
アロマルトール 0.5
アミノ酢酸 0.20
塩酸ピリドキシン 0.05
フエノールスルホン酸亜鉛 0.30
プロピレングリコール 8.00
エタノール 5.00
精 製 水 86.35
香料および防腐剤 少 量
処方例 2〔パツク〕
(成 分) (重量部)
ピロメコン酸 0.25
アミノ酢酸 0.20
フエノールスルホン酸亜鉛 0.30
プロピレングリコール 13.00
カルボキシビニルポリマー 1.20
水酸化ナトリウム 0.14
エタノール 2.50
酸化チタン 0.02
精 製 水 82.54
香料および防腐剤 少 量
処方例 3〔パツク〕
(成 分) (重量部)
ポリビニルアルコール 15.00
ポリビニルピロリドン 4.00
プロピレングリコール 6.00
エタノール 10.00
アロマルトール 0.5
精 製 水 69.70
香料および防腐剤 少 量
処方例 4〔ミルクローシヨン〕
(成 分) (重量部)
ステアリン酸 2.00
セタノール 0.50
ラノリン 2.00
オレイルオレエート 2.00
スクワラン 3.00
流動パラフイン 8.00
乳 化 剤 2.60
ピロメコン酸 0.2
トリエタノールアミン 1.00
プロピレングリコール 4.00
精 製 水 74.90
香料、酸化防止剤および防腐剤 少 量
処方例 5〔バニシングクリーム〕
(成 分) (重量部)
MCステアリン酸 8.00
ミツロウ 5.00
セタノール 3.00
ラノリン 2.00
ミリスチン酸イソプロピル 6.00
流動パラフイン 7.00
オリーブ油 2.00
乳 化 剤 5.50
ピロメコン酸 0.4
トリエタノールアミン 0.60
プロピレングリコール 3.00
精 製 水 57.70
香料、酸化防止剤および防腐剤 少 量
処方例 6〔コールドクリーム〕
(成 分) (重量部)
ミツロウ 10.00
セレシン 7.00
白色ワセリン 3.00
ラノリン 3.00
ミリスチン酸イソプロピル 3.00
スクワラン 4.00
流動パラフイン 40.00
ポリオキシエチレンセチルエーテル 2.70
乳 化 剤 2.30
アロマルトール 0.3
プロピレングリコール 2.00
精 製 水 23.00
香料、酸化防止剤および防腐剤 少 量
(メラニン生成抑制試験)
処方例5のクリームを用いて20〜50才の女性65
人の色素沈着症患者に対して3カ月間にわたつて
1日1回患部に塗布した。Prescription example 1 [Lotion] (Ingredients) (Parts by weight) Allomaltol 0.5 Aminoacetic acid 0.20 Pyridoxine hydrochloride 0.05 Zinc phenolsulfonate 0.30 Propylene glycol 8.00 Ethanol 5.00 Refined water 86.35 Fragrances and preservatives Small amount prescription example 2 [Pack] (Ingredients) (Parts by weight) Pyromeconic acid 0.25 Aminoacetic acid 0.20 Zinc phenolsulfonate 0.30 Propylene glycol 13.00 Carboxyvinyl polymer 1.20 Sodium hydroxide 0.14 Ethanol 2.50 Titanium oxide 0.02 Purified water 82.54 Flavoring and preservative Small amount formulation example 3 [Package] ] (Ingredients) (Parts by weight) Polyvinyl alcohol 15.00 Polyvinylpyrrolidone 4.00 Propylene glycol 6.00 Ethanol 10.00 Aromaltol 0.5 Purified water 69.70 Fragrances and preservatives Small amount formulation example 4 [Milk lotion] (Ingredients) (Parts by weight) Stearic acid 2.00 Setanol 0.50 Lanolin 2.00 Oleyl oleate 2.00 Squalane 3.00 Liquid paraffin 8.00 Emulsifier 2.60 Pyromeconic acid 0.2 Triethanolamine 1.00 Propylene glycol 4.00 Purified water 74.90 Fragrances, antioxidants and preservatives Small quantity formulation example 5 [Vanishing Cream ] (Ingredients) (Parts by weight) MC stearic acid 8.00 Beeswax 5.00 Setanol 3.00 Lanolin 2.00 Isopropyl myristate 6.00 Liquid paraffin 7.00 Olive oil 2.00 Emulsifier 5.50 Pyromeconic acid 0.4 Triethanolamine 0.60 Propylene glycol 3.00 Purified water 57 .70 Fragrances, Antioxidants Semed and preservatives small quantity prescription Example 6 [cold cream] (component) (weight part) white vassin 7.00 white vassin 3.00 ranoline 3.00 msopropyl 3.00 squaralan 4.00 paling paraphroses polyoxyethylene ether 2.370 Emps 2.3. 0 Aroma Lutol 0.3 Propylene glycol 2.00 Purified water 23.00 Fragrances, antioxidants and preservatives Small amounts (Melanin production inhibition test) Women aged 20-50 using the cream of Formulation Example 5 65
It was applied once a day to the affected areas of human patients with hyperpigmentation for three months.
その結果、被検患者のうち症状が完治したもの
21名、症状の改善をみたもの32名、および変化の
なかつたもの12名であつた。 As a result, among the patients tested, the symptoms were completely cured.
21 patients showed improvement in symptoms, 32 patients showed improvement in symptoms, and 12 patients showed no change.
この試験結果から、何らかの症状の改善をみた
ものは81%にも達し、顕著なメラニン生成抑制効
果があることが判明した。 The results of this test showed that as many as 81% of patients saw some improvement in symptoms, indicating that the drug had a significant melanin production suppressing effect.
また処方例6のコールドクリームについても同
様の試験を行なつたところ、同程度の結果がえら
れた。 Further, when a similar test was conducted on the cold cream of Formulation Example 6, similar results were obtained.
図面はアロマルトールのメラニン生成抑制効果
を示すための、ドーパクロームの生成量と時間と
の関係を示すグラフである。
The figure is a graph showing the relationship between the amount of dopachrome produced and time to show the melanin production inhibiting effect of allomaltol.
Claims (1)
れる2−アルキル−5−オキシ−γ−ピロン化合
物を含有せしめたことを特徴とする色白化粧料。 2 2−アルキル−5−オキシ−γ−ピロン化合
物の含有量が5重量%以下である特許請求の範囲
第1項記載の色白化粧料。 3 2−アルキル−5−オキシ−γ−ピロン化合
物がアロマルトールである特許請求の範囲第1項
または第2項記載の色白化粧料。[Claims] 1. General formula: A fair-skinned cosmetic containing a 2-alkyl-5-oxy-γ-pyrone compound represented by the formula (wherein R is a lower alkyl group). 2. The fair-skinned cosmetic according to claim 1, wherein the content of the 2-alkyl-5-oxy-γ-pyrone compound is 5% by weight or less. 3. A fair-skinned cosmetic according to claim 1 or 2, wherein the 2-alkyl-5-oxy-γ-pyrone compound is aromaltol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2033081A JPS57134409A (en) | 1981-02-13 | 1981-02-13 | Whitening cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2033081A JPS57134409A (en) | 1981-02-13 | 1981-02-13 | Whitening cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57134409A JPS57134409A (en) | 1982-08-19 |
JPS6160802B2 true JPS6160802B2 (en) | 1986-12-23 |
Family
ID=12024122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2033081A Granted JPS57134409A (en) | 1981-02-13 | 1981-02-13 | Whitening cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57134409A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0655082B2 (en) * | 1985-02-27 | 1994-07-27 | 株式会社薬理学中央研究所 | Method for preventing or recoloring body color of red seafood by .GAMMA.-pyrone derivative |
JPH0314508A (en) * | 1989-06-12 | 1991-01-23 | Sansho Seiyaku Co Ltd | External drug preparation for suppressing melanogenesis |
JPH03127712A (en) * | 1989-10-09 | 1991-05-30 | Sansho Seiyaku Co Ltd | Agent for external application |
WO2002053121A1 (en) * | 2000-12-30 | 2002-07-11 | Lg Household & Healthcare Co., Ltd. | Cosmetic for skin whitening containing acyl substituted derivatives of glucose or sucrose |
US20090215887A1 (en) * | 2008-02-25 | 2009-08-27 | Eastman Chemical Company | 5-hydroxy-2-methyl-4h-pyran-4-one esters as novel tyrosinase inhibitors |
US8183398B2 (en) | 2008-02-25 | 2012-05-22 | Eastman Chemical Company | 5-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitors |
-
1981
- 1981-02-13 JP JP2033081A patent/JPS57134409A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57134409A (en) | 1982-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5153230A (en) | Topical skin cream composition | |
CA1220717A (en) | Composition containing benzoyl peroxide and at least one sun-screen for the treatment of acne | |
JPS61155302A (en) | Skin color-lightening cosmetic | |
TW477706B (en) | Skin tanning compositions and method | |
US4285967A (en) | Cosmetic preparation for reducing redness of blemishes | |
FR2577805A1 (en) | SKIN TREATMENT COMPOSITION BASED ON HYDROQUINONE GLUCOSIDE | |
CA1171265A (en) | Sodium lactate, glycerine, urea and native collagen based wetting composition | |
JPH0552806B2 (en) | ||
CA1341273C (en) | Antioxidant system based on stabilized ascorbyl ester and compositions containing the same | |
FR2743813A1 (en) | STABLE GELIFIED COMPOSITION WITH HIGH ELECTROLYTE CONTENT | |
JP3135943B2 (en) | Whitening agent | |
JPH0725742A (en) | Fair-skinning cosmetic | |
JPS63192705A (en) | External agent for skin | |
JPS6160802B2 (en) | ||
JPS6245527A (en) | Preventive and remedy for gray hair | |
US5993835A (en) | Skin-whitening agent | |
JPS5811922B2 (en) | Keshiyouriyo | |
US4362747A (en) | Cosmetic cream pack formulation | |
JP2799603B2 (en) | Whitening cosmetics | |
FR2816852A1 (en) | Combination of colorant and emulsifier capable of forming stable lamellar emulsion, giving enhanced colorant stability in cosmetic or dermatological compositions | |
JPH0853327A (en) | Hair tonic composed of allantoin or its derivative | |
JPS6270309A (en) | Skin beautifying cosmetic | |
JP2696523B2 (en) | Anti-dandruff agent and hair cosmetic | |
JP3055826B2 (en) | Skin cosmetics | |
JPS58131911A (en) | Cosmetic for fair-complexioned face containing fatty acid ester of quercetin |